← Eichor
Condition: Rasopathy Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Rasopathy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Solid Tumors in RASopathies
NA · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT05761314Familial Investigations of Childhood Cancer Predisposition
Phase N/A · 1 location(s) · St. Jude Children's Research Hospital · NCT03050268Pubertal Development in Patients with RASopathies
Phase N/A · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06776380Hematological Anomalies in Children With Rasopathy
Phase N/A · 14 location(s) · Assistance Publique - Hôpitaux de Paris · NCT04286360Clinical, Genetic, and Epidemiologic Study of Children and Adults With RASopathies
Phase N/A · 2 location(s) · National Cancer Institute (NCI) · NCT04888936Acceptance and Commitment Therapy for Caregivers of Children With a RASopathy: An Internal Pilot Feasibility Study and F
NA · 1 location(s) · National Cancer Institute (NCI) · NCT05361811Retrospective Natural History Study of RASopathy-associated Cardiomyopathy (RAS-CM)
Phase N/A · 1 location(s) · Deutsches Herzzentrum Muenchen · NCT07344480Study of the Thyroid Function and Echostructural Morphology in Patients Affected With Rasopathies (ECORAS2023)
Phase N/A · 1 location(s) · University of Bari Aldo Moro · NCT06489067RASopathy Biorepository
Phase N/A · 1 location(s) · Children's Hospital Medical Center, Cincinnati · NCT04395495
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.